WASHINGTON — The FDA on Friday accredited the Guardant360 CDx assay to establish metastatic lung most cancers patients who lift explicit EGFR mutations, making them…
WASHINGTON — The FDA on Friday accredited the Guardant360 CDx assay to establish metastatic lung most cancers patients who lift explicit EGFR mutations, making them…